Quantum BioPharma Balance Sheet Health
Financial Health criteria checks 5/6
Quantum BioPharma has a total shareholder equity of $10.2M and total debt of $615.6K, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are $15.2M and $5.0M respectively.
Key information
6.0%
Debt to equity ratio
US$615.56k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.33m |
| Equity | US$10.20m |
| Total liabilities | US$5.04m |
| Total assets | US$15.25m |
Financial Position Analysis
Short Term Liabilities: QNTM's short term assets ($10.0M) exceed its short term liabilities ($5.0M).
Long Term Liabilities: QNTM has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: QNTM has more cash than its total debt.
Reducing Debt: QNTM's debt to equity ratio has increased from 2.9% to 6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: QNTM has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: QNTM is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.